These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 24743190)

  • 1. [Tumor lysis syndrome and clinical guidelines].
    Ishizawa K
    Gan To Kagaku Ryoho; 2014 Feb; 41(2):135-40. PubMed ID: 24743190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Guidelines for the management of pediatric and adult tumor lysis syndrome: an evidence-based review.
    Coiffier B; Altman A; Pui CH; Younes A; Cairo MS
    J Clin Oncol; 2008 Jun; 26(16):2767-78. PubMed ID: 18509186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recommendations for the evaluation of risk and prophylaxis of tumour lysis syndrome (TLS) in adults and children with malignant diseases: an expert TLS panel consensus.
    Cairo MS; Coiffier B; Reiter A; Younes A;
    Br J Haematol; 2010 May; 149(4):578-86. PubMed ID: 20331465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An integrated clinical approach for the identification, prevention, and treatment of tumor lysis syndrome.
    Mughal TI; Ejaz AA; Foringer JR; Coiffier B
    Cancer Treat Rev; 2010 Apr; 36(2):164-76. PubMed ID: 20031331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Tumor lysis syndrome].
    Hagino T
    Gan To Kagaku Ryoho; 2010 Jun; 37(6):984-8. PubMed ID: 20567098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute tumor lysis syndrome in solid tumors--a case report and review of the literature.
    Baeksgaard L; Sørensen JB
    Cancer Chemother Pharmacol; 2003 Mar; 51(3):187-92. PubMed ID: 12655435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor lysis syndrome and acute kidney injury: evaluation, prevention, and management.
    Abu-Alfa AK; Younes A
    Am J Kidney Dis; 2010 May; 55(5 Suppl 3):S1-13; quiz S14-9. PubMed ID: 20420966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clarifying the role of rasburicase in tumor lysis syndrome.
    Sood AR; Burry LD; Cheng DK
    Pharmacotherapy; 2007 Jan; 27(1):111-21. PubMed ID: 17192165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk evaluation, prophylaxis, and treatment of tumor lysis syndrome: consensus of an Italian expert panel.
    Pession A; Masetti R; Gaidano G; Tosi P; Rosti G; Aglietta M; Specchia G; Porta F; Pane F
    Adv Ther; 2011 Aug; 28(8):684-97. PubMed ID: 21779956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention and Treatment of Tumor Lysis Syndrome in the Era of Onco-Nephrology Progress.
    Matuszkiewicz-Rowinska J; Malyszko J
    Kidney Blood Press Res; 2020; 45(5):645-660. PubMed ID: 32998135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rasburicase for the treatment of tumor lysis in hematological malignancies.
    Malaguarnera G; Giordano M; Malaguarnera M
    Expert Rev Hematol; 2012 Feb; 5(1):27-38. PubMed ID: 22272702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of Single-dose Rasburicase in Patients With Lymphoid Malignancies at a High Risk for Tumor Lysis Syndrome.
    Jeon YW; Kwak DH; Park SS; Yoon JH; Lee SE; Eom KS; Kim YJ; Kim HJ; Lee S; Min CK; Lee JW; Min WS; Cho SG
    Clin Lymphoma Myeloma Leuk; 2017 Sep; 17(9):595-603. PubMed ID: 28711571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant urate oxidase for prevention of hyperuricemia and tumor lysis syndrome in lymphoid malignancies.
    Ribeiro RC; Pui CH
    Clin Lymphoma; 2003 Mar; 3(4):225-32. PubMed ID: 12672271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A review of tumour lysis syndrome with targeted therapies and the role of rasburicase.
    Bose P; Qubaiah O
    J Clin Pharm Ther; 2011 Jun; 36(3):299-326. PubMed ID: 21501203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention and treatment of tumor lysis syndrome, and the efficacy and role of rasburicase.
    Alakel N; Middeke JM; Schetelig J; Bornhäuser M
    Onco Targets Ther; 2017; 10():597-605. PubMed ID: 28203093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of pediatric tumor lysis syndrome.
    Tazi I; Nafl H; Elhoudzi J; Mahmal L; Harif M
    Arab J Nephrol Transplant; 2011 Sep; 4(3):147-54. PubMed ID: 22026339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effective treatment and prophylaxis of hyperuricemia and impaired renal function in tumor lysis syndrome with low doses of rasburicase.
    Hummel M; Reiter S; Adam K; Hehlmann R; Buchheidt D
    Eur J Haematol; 2008 Apr; 80(4):331-6. PubMed ID: 18081720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The management of tumor lysis syndrome.
    Rampello E; Fricia T; Malaguarnera M
    Nat Clin Pract Oncol; 2006 Aug; 3(8):438-47. PubMed ID: 16894389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor lysis syndrome in patients with acute myeloid leukemia: identification of risk factors and development of a predictive model.
    Montesinos P; Lorenzo I; Martín G; Sanz J; Pérez-Sirvent ML; Martínez D; Ortí G; Algarra L; Martínez J; Moscardó F; de la Rubia J; Jarque I; Sanz G; Sanz MA
    Haematologica; 2008 Jan; 93(1):67-74. PubMed ID: 18166787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumour lysis syndrome.
    Calvo Villas JM
    Med Clin (Barc); 2019 May; 152(10):397-404. PubMed ID: 30612747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.